Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 May 2020 07:00

RNS Number : 2667N
Quixant PLC
19 May 2020
 

19 May 2020

Quixant plc

("Quixant" or the "Company" or the "Group")

Trading Update

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Quixant (AIM: QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, is pleased to provide an update on the business in light of the current global disruption caused by COVID-19.

COVID-19 trading update

During this period of disruption to our business, the health and wellbeing of our staff is our highest priority, and we are pleased to report that our staff members continue to operate normally having transitioned smoothly to remote working wherever appropriate.

As previously stated, the global gaming industry remains largely closed down and consequentially demand for Quixant's gaming products has been impacted and receivables collection has been slower than normal. Positive signs of recovery are starting to show and from week commencing 11th May, we started to see the first reopening of venues in the US and robust attendance from players.

The Densitron business is performing well with healthy demand for its products in a range of sectors and coupled with robust gross margins. In keeping with this performance, Densitron has not experienced any material reduction in customer payments.

The Board believes that once we start to see the gradual reopening of more of the economy, multiple opportunities across the Gaming and Densitron businesses to deliver long term growth will present themselves and we are ensuring that the business is in an ideal position to take advantage of these opportunities when they arise.

Working capital position

The Company's balance sheet remains strong with net cash at end April 2020 of $14.8m ($16.1m as at 31 December 2019). In addition, the Board has access to as yet unutilised lines of credit totalling $3.0m. In addition, we are investigating whether it may be possible to access other COVID-19 related Government backed loan schemes.

The Board has taken measures to reduce the Company's overhead base by around 10% compared to the 2020 budget and Board members have taken a minimum of a 25% reduction in salary. We are continuing to review our cost base.

The Board is confident that, with the Company's cash reserves and borrowing facilities, it has sufficient working capital to support a prolonged slowdown in the business should the need arise, and that the Group's balance sheet is sufficiently resilient to withstand the current crisis.

 

For further information please contact:

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

 

 

Nominated Adviser and Broker:

 

finnCap Ltd

Tel: +44(0)20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)

 

Alice Lane (Corporate Broking)

 

 

 

Financial PR:

Tel: +44 (0) 20 3405 0205

Alma PR

 

John Coles / Susie Hudson / David Ison

 

   

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVVLFFBELLBBB
Date   Source Headline
11th Jun 20193:00 pmRNSHolding(s) in Company
21st May 20194:39 pmRNSHolding(s) in Company
3rd May 201911:07 amRNSDirector/PDMR Shareholding
1st May 20194:09 pmRNSGrant of Options
1st May 20194:03 pmRNSExercise of Options
18th Apr 20194:49 pmRNSExercise of Options
16th Apr 201911:13 amRNSResult of AGM
10th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:57 pmRNSGrant of Options
4th Apr 20191:54 pmRNSGrant of Options
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20197:00 amRNSFinal Results
24th Jan 20197:00 amRNSTrading Update and Notice of Results
21st Jan 20192:51 pmRNSHolding(s) in Company
4th Jan 201910:13 amRNSBoard Change
22nd Oct 20189:41 amRNSIssue of Equity & PDMR Dealing
5th Oct 20185:50 pmRNSIssue of Options & Director/PDMR Dealings
21st Sep 20187:40 amRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
19th Jul 20187:00 amRNSTrading Update and Notice of Results
4th Jul 20184:36 pmRNSDirector/PDMR Shareholding
14th May 20188:07 amRNSHolding(s) in Company
11th May 20184:10 pmRNSDirector/PDMR Dealings
30th Apr 20187:00 amRNSDirector/PDMR Shareholdings
27th Apr 20182:15 pmRNSResult of placing in Quixant plc
27th Apr 20189:50 amRNSProposed placing in Quixant plc
24th Apr 201811:14 amRNSResult of AGM
5th Apr 20183:23 pmRNSGrant of Options
26th Mar 20184:18 pmRNSDividend Timetable
22nd Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSBoard Changes and Appointment of CFO
2nd Feb 201810:08 amRNSHolding(s) in Company
25th Jan 20187:00 amRNSTrading Update and Notice of Results
28th Nov 20171:59 pmRNSDirector/PDMR Shareholding
27th Oct 20175:15 pmRNSIssue of Equity and Director/PDMR Shareholding
4th Oct 20172:23 pmRNSHolding(s) in Company
21st Sep 20177:03 amRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
11th Sep 20173:00 pmRNSHolding(s) in Company
22nd Aug 201710:16 amRNSHolding(s) in Company
7th Aug 20177:00 amRNSNotice of Results
24th Jul 20177:00 amRNSTrading Update and Notice of Results
13th Jul 201710:25 amRNSHolding(s) in Company
2nd Jun 20178:00 amRNSDirector/PDMR Shareholding
12th May 20174:55 pmRNSDirector/PDMR Shareholding
4th May 20172:37 pmRNSIssue of Equity and Director/PDMR Dealings
25th Apr 201712:15 pmRNSResult of AGM
22nd Mar 201712:00 pmRNSBoard Appointment
22nd Mar 201710:00 amRNSDividend Timetable
22nd Mar 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.